세계 검안경 시장 규모는 2024-2030년의 예측 기간 동안 연평균 4.73% 성장할 것으로 예상됩니다. 검안경에 대한 수요 증가는 주로 안과 질환의 유병률 증가와 노화 황반변성의 유병률 증가에 기인합니다. 또한, 안과 의료의 필요성과 장애 치료에 대한 환자들의 인식이 높아지면서 검안경 시장의 전체 성장률을 높일 것으로 예상됩니다. 또한, 직접 디지털 이미징, 향상된 콘트라스트, 낮은 광선 조사 수준과 같은 이점을 제공하는 레이저 검안경 기술의 발전은 시장을 강화하고 2024-2030년의 예측 기간 동안 검안경 시장의 전반적인 성장에 기여할 것으로 예상됩니다.
시장 역학
검안경 시장은 시력 장애 및 실명과 같은 안과 질환의 유병률 증가, 노인성 황반변성 유병률 증가, 안과 의료의 필요성에 대한 환자 인식 증가 등 다양한 이유로 인해 제품 수요가 증가하고 있습니다.
검안경은 많은 안과 질환을 발견하고 치료하는 데 사용됩니다. 세계보건기구(WHO)(2022)에 따르면 2020년 전 세계 22억 명에 가까운 사람들이 근거리 또는 원거리 시력 장애를 앓고 있습니다. 그 중 10억 명은 치료되지 않은 굴절 이상, 백내장, 녹내장, 각막 혼탁, 당뇨병성 망막증, 트라코마, 치료되지 않은 노안으로 인한 근거리 시력 장애로 인한 중등도 또는 중증 원거리 시력 장애 또는 실명자입니다. 또한 같은 자료에 따르면 2020년 시력 장애 및 실명 환자의 대부분은 50세 이상이었지만, 시력 저하는 모든 연령대의 사람들에게 영향을 미칠 수 있습니다. 검안경은 눈의 장애를 감지하고 진단하는 데 사용되기 때문에 시장에서 수요가 증가하고 있습니다.
또한 검안경은 녹내장, 백내장 등 다양한 유전성 질환을 감지하고 치료하기 위해 의사와 의사들이 널리 사용하고 있으며, 이는 시장 성장을 가속하고 있습니다. 예를 들어, 미국 질병예방통제센터(CDC)가 2020년 발표한 자료에 따르면 2020년 미국에서는 40세 이상 미국인 180만 명 이상이 노화성 황반변성(AMD)을 앓고 있으며, 약 300만 명이 AMD를 앓고 있는 것으로 추산됩니다. 검안경은 망막의 상세한 사진을 제공하여 AMD를 진단하는 데 도움이 됩니다.
또한 녹내장 유병률 증가도 시장 성장 촉진요인 중 하나입니다. 녹내장은 지속적인 고혈압으로 인한 과도한 안압으로 인해 시신경이 손상되는 것이 특징입니다. 예를 들어, 2022년 발표된 세계보건기구(WHO) 자료에 따르면 2020년 전 세계 30-79세 성인 중 약 12억 8,000만 명이 고혈압을 앓고 있는 것으로 추산됩니다. 앞서 언급했듯이 고혈압은 녹내장의 주요 원인 중 하나이기 때문에 녹내장 유병률을 높일 수 있습니다. 또한 녹내장 진단은 시신경과 안압을 검사하고 검안경으로 각막의 구조를 검사하여 진단합니다. 따라서 고혈압 유병률 증가는 녹내장 환자 증가로 이어져 궁극적으로 검안경 시장 성장을 가속할 것입니다.
또한 시장에서 신제품 출시는 제품 수요를 촉진할 것입니다. 예를 들어, 2022년 5월, 진단 기기 제조 분야의 세계 리더인 HEINE은 미국과 캐나다에서 최신 간접 검안기인 OMEGA 600을 출시했으며, 백내장 환자의 망막 검사를 개선하기 위해 고안된 OMEGA 600은 세척과 소독이 쉬운 세련된 표면 디자인과 새로운 초경량 배터리를 갖춘 가장 가벼운 하이엔드 간접 검안기입니다. 완전히 새로운 디자인과 새로운 초경량 배터리를 탑재한 가장 가벼운 하이엔드급 간접 검안경으로, 백내장 환자의 망막 검사를 개선하도록 설계되었습니다.
이러한 다양한 분야에서 안저경 사용이 증가하고 눈 관련 질환의 유병률이 증가함에 따라 검안경에 대한 수요가 증가하고 검안경 시장의 성장도 가속화되고 있습니다.
그러나 저개발국가의 숙련된 외과의사 부족과 높은 장비 비용은 검안경 시장의 성장을 저해하는 요인으로 작용할 수 있습니다.
또한 진행 중인 코로나19 팬데믹은 AMD, 녹내장 및 기타 안과 관련 질환을 앓고 있는 환자의 입원이 코로나19 환자보다 우선순위가 낮았기 때문에 검안경 시장에도 약간의 영향을 미쳤습니다. 바이러스 확산을 억제하기 위해 엄격한 봉쇄 조치가 취해지면서 시장이 크게 감소했습니다. 이로 인해 원자재 및 기타 자원 공급이 중단되어 제조 공정이 중단되었습니다. 또한 전염병 기간 동안 선택적 수술도 일시적으로 중단되어 제품 사용과 수요를 방해했습니다. 그러나 많은 사람들이 예방 접종을 받고 원자재와 자원이 회복되면서 검안경 시장은 다시 활기를 되찾고 있습니다.
이 보고서는 세계 검안경 시장에 대해 조사 분석했으며, 시장 규모와 예측, 촉진요인 및 과제, 기업 및 제품 프로파일 등의 정보를 제공합니다.
Ophthalmoscopes Market By Product Type (Direct Ophthalmoscope And Indirect Ophthalmoscope [Monocular Indirect Ophthalmoscopes And Binocular Indirect Ophthalmoscopes]), By Application Type (Glaucoma, Retinal Disease, Diabetes Eye Disease, And Others), By End-User (Hospitals And Clinics, Ambulatory Surgical Centers, And Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing prevalence of ophthalmic disease such as vision impairment and blindness and increasing prevalence of age-related macular degeneration
Global ophthalmoscopes market is estimated to grow at a CAGR of 4.73% during the forecast period from 2024 to 2030. The increase in demand for ophthalmoscopes is primarily attributed to the increased prevalence of ophthalmic disease and increased prevalence of age-related macular degeneration. Further, rising awareness among patients about the need of eye care and the treatment of its disorders will augment the overall market growth of ophthalmoscope. Moreover, technological advancements in laser ophthalmoscopes which offer advantages like direct digital imaging, improved contrast and lower levels of light exposure among others are anticipated to bolster the market, thereby contributing to the ovrall growth of the ophthalmoscopes market during the forecast period from 2024-2030.
Ophthalmoscopes Market Dynamics:
The ophthalmoscopes market is witnessing a growth in product demand owing to various reasons such as increased prevalence of ophthalmic disease like vision impairment or blindness, increased prevalence of age-related macular degeneration, and the rising awareness among patients about the need of eye care across the world are anticipated to bolster the market.
The ophthalmoscopes are continuously been used for the detection and treatment of many ophthalmic ailments. According to World Health Organization (WHO) 2022, in the year 2020 nearly 2.2 billion people globally had a near or distance vision impairment. Out of which one billion people were those with moderate or severe distance vision impairment or blindness due to unaddressed refractive error (88.4 million), cataract (94 million), glaucoma (7.7 million), corneal opacities (4.2 million), diabetic retinopathy (3.9 million), and trachoma (2 million), as well as near vision impairment caused by unaddressed presbyopia (826 million). Moreover, as per the same source, in the year 2020 majority of people with vision impairment and blindness were over the age of 50 years; however, vision loss can affect people of all ages. Ophthalmoscopes are used to detect and diagnose the impairments in the eyes thereby increasing the demand of the device in the market.
Further, ophthalmoscopes are widely used by physicians and doctors for the detection and treatment of various genetic disorders like glaucoma and cataract, thus driving the market growth. For instance, as per the data published by Centers for Disease Control and Prevention (CDC) in the year 2020, it was estimated that in the United States in 2020 more than 1.8 million Americans over the age of 40 were affected by age-related macular degeneration (AMD) and almost 3 million people were affected by AMD. Ophthalmoscopes provide detailed photo of the retina which is useful in the diagnosis of AMD ultimately increasing the demand of the device in the market.
Another factor which will drive the market of ophthalmoscopes is the increasing prevalence of glaucoma. Glaucoma is characterized by damaged optic nerve due to excessive eye pressure which may be due to persistent high blood pressure. For instance, according WHO data published in 2022, it was estimated that in the year 2020 about 1.28 billion adults aged 30-79 years worldwide had hypertension. As stated above hypertension is one the major cause of glaucoma so it may increase the prevalence of glaucoma. Additionally, diagnosis of glaucoma is done by examining the optic nerve, eye pressure and by checking corneal structure through ophthalmoscopes. Thus, the increasing prevalence of hypertension will lead to rise in glaucoma patients ultimately driving the market growth of ophthalmoscopes.
Moreover, the new product launches in the market, in turn, will drive the product demand. For instance, in May 2022, HEINE, one of the global leader in the manufacture of diagnostic instruments announced that they have launched its newest indirect ophthalmoscope, the OMEGA 600 in US and Canada. It is designed to improve retina exams for cataract patients, and a sophisticated surface design for easy cleaning and disinfection. OMEGA 600, have an entirely new design that makes it the lightest high-end indirect ophthalmoscopes with a new ultralight battery.
Thus, due to the increasing utilization of ophthalmoscopes in various areas of application and increasing prevalence of eye-related disorders, there will be a rising demand for ophthalmoscopes, in turn increasing the ophthalmoscopes market growth.
However, dearth of skilled surgeons in lower-economic countries and high cost of the device may be certain limiting factors of the ophthalmoscopes market growth.
Additionally, the ongoing COVID-19 pandemic has slightly impacted the market for ophthalmoscopes as hospital admissions for patients suffering from AMD, glaucoma, and other eye-related disorders were not a priority in comparison to the patients suffering from coronavirus. There was a significant drop in the market, attributed to the imposition of stringent lockdowns to curb the spread of the virus. Due to this supply of raw materials and other resources was stopped, halting the manufacturing process. Furthermore, elective surgeries were also temporarily stopped during the pandemic hampering the product uses and it's demand. However, with masses being vaccinated and with the upturn of raw materials and resources, the ophthalmoscopes market has picked up the momentum again.
Ophthalmoscopes Market Segment Analysis:
Ophthalmoscopes Market by Product Type (Direct Ophthalmoscope and Indirect Ophthalmoscope [Monocular Indirect Ophthalmoscope and Binocular Indirect Ophthalmoscopes]), by Application Type (Glaucoma, Retinal Disease, Diabetes Eye Disease, and Others), by End-User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the ophthalmoscopes market, the indirect ophthalmoscopes are estimated to hold a significant share in the year 2023. This can be ascribed due to the various advantages that are associated with the devices Such as rising technological advancements in indirect ophthalmoscopes.
For instance, ophthalmoscopes are used in detection of eye-related disorders. It offers a pain-less experience to the patients, as these devices do not require any cuts on the skin. The indirect ophthalmoscope delivers a stronger source of light, greater opportunity for stereoscopic inspection of the eyeball interior, and have a specifically designed objective lens. These devices are used in treatment and diagnosis of detachments, holes, and retinal tears.
Indirect ophthalmoscopes are of two types: monocular indirect ophthalmoscopes and binocular indirect ophthalmoscopes. The monocular indirect ophthalmoscopes offer a wider field of view allowing both the central and peripheral retina to be seen clearly. It also offers higher magnification levels than the traditional ophthalmoscope.
The binocular indirect ophthalmoscopes offers three-dimensional pictures and also provides superior stereopsis. Moreover, indirect ophthalmoscope offers brighter image as compared to direct ophthalmoscopes.
The advantages of indirect ophthalmoscopes will offer a significant market growth opportunity for the device. The device is commonly used in wide range of conditions like glaucoma, retinal detachment, diabetic retinopathy, swollen optical disc, eye tumors, and many more. Thus, owing to the wide application of the device, there will be an increase in the demand for indirect ophthalmoscopes, which in turn will drive the ophthalmoscopes market growth.
North America is expected to dominate the overall Ophthalmoscopes Market:
Among all the regions, North America is expected to account for the largest share in the global ophthalmoscopes market. Growing incidence of chronic diseases such as cataract, glaucoma, and diabetic retinopathy will increase the demand for ophthalmoscopes in North America, leading to a rise in the overall ophthalmoscopes market growth.
For instance, as per the National Institutes of Health (NIH) 2022, by 2050, the number of people in the US with cataract is expected to double from 24.4 million to about 50 million. The majority of cases will affect white people, however Hispanic Americans are expected to have the most rapid increase in prevalence from 1.76 million cases to 9.51 million in the forecast period from 2024-2030. Also, as per the study done by Glaucoma patient's organization in the year 2019-2020, it was concluded that in the US blindness is the third most feared health problem. As per the same source, it was estimated that 79.6 million individuals had glaucoma in 2020. This number is likely to increase to 111.8 million individuals in 2040. Presence of glaucoma is confirmed by performing various diagnostic tests using ophthalmoscopes. Therefore, owing to the increasing prevalence of glaucoma the market of ophthalmoscopes will rise during the forecast period from 2024-2030.
Furthermore, diabetes mellitus which is one the chronic disease can cause diabetic retinopathy, a complication that affects the eyes. Over time, too much sugar in the blood can lead to the blockage of the tiny blood vessels that nourish the retina, cutting off its blood supply. As a result, the eye attempts to grow new blood vessels but these new blood vessels don't develop properly and can leak easily, leading to mild vision problems or blindness. For instance, according to NIH 2020, by the year 2050, the number of Americans with diabetic retinopathy is expected to nearly double, from 7.7 million to 14.6 million and the Hispanic Americans are expected to see the greatest increase in cases, rising more than three-fold from 1.2 million to 5.3 million. Also, as per the Diabetes in Canada Organization published in 2020, it was estimated that in the year 2019-2020, 29% of Canadians lived with diabetes or prediabetes, 10% people lived with diagnosed diabetes, 6.1% people lived with prediabetes, 7.0% people lived with high blood glucose, and 1.7% lived with undiagnosed high blood glucose.. From the above data it can be concluded that the increase in prevalence of diabetes rise in North America ultimately leading to rise in the cases of diabetic retinopathy. Further, the diagnosis of diabetic retinopathy is done by examining the structure of retina and optic nerves using ophthalmoscopes. Therefore, propelling the market growth of the device in North America.
Thus, all the above-mentioned factors are anticipated to propel the market for ophthalmoscopes in the North America region.
Ophthalmoscopes Market Key Players:
Some of the key market players operating in the ophthalmoscopes market include Hill-Rom Services Inc., HEINE Optotechnik GmbH & Co. KG, Keeler Itd, US Ophthalmic., Rudolf Riester GmbH, Opticlar, Zumax Medical Co.,Ltd., GirodMedical., AdamRouilly, Timesco Healthcare Ltd, Zhejiang Honsun Medical Technology Co., Ltd., IRIDEX Corporation, NIDEK CO., LTD., OSCAR BOSCAROL S.r.l., American Diagnostic Corporation, Lumenis Be Ltd., Veatch Ophthalmic Instruments, KIRCHNER & WILHELM GmbH + Co. KG, CenterVua SpA, oDocs Eye Care, among others.
Recent Developmental Activities in the Ophthalmoscopes Market:
In December 2022, Baxter International Inc., a global medtech leader announced that it has completed the acquisition of Hillrom, one of the leading manufacturer of ophthalmoscope. Baxter paid USD 156 in cash for each outstanding share of Hillrom common stock for a purchase price of USD 10.5 billion.
In August 2022, CenterVue SpA accounced the approval of 510(k) approval for Device EIDON. EIDON is the Confocal system that combines the best features of Scanning Laser Ophthalmoscopy (SLO) systems with those of standard fundus imaging systems.
Key Takeaways from the Ophthalmoscopes Market Report Study
Target Audience who can be benefited from this Ophthalmoscopes Market Report Study
Frequently Asked Questions for Ophthalmoscopes Market:
An ophthalmoscopes or fundoscopes, is a medical device that allows a physician or doctor to see inside the fundus of the eye and other structures, like retina, optic disc, choroid, and blood vessels. It is used to detect and evaluate symptoms of retinal detachment or eye diseases such as glaucoma, AMD, diabetic retinopathy and others.
Global ophthalmoscopes market is estimated to grow at a CAGR of 4.73% during the forecast period from 2024 to 2030.
The ophthalmoscopes market is witnessing a positive market growth owing to increased prevalence of ophthalmic disease, increased prevalence of age-related macular degeneration, rising awareness among patients about need of eye care and its treatment, and technological advancements in laser ophthalmoscopes that offer advantages like direct digital imaging, improved contrast and lower levels of light exposure across the world are anticipated to bolster the market.
Some of the key market players operating in the Ophthalmoscopes market include Hill-Rom Services Inc., HEINE Optotechnik GmbH & Co. KG, Keeler Itd, US Ophthalmic., Rudolf Riester GmbH, Opticlar, Zumax Medical Co.,Ltd., GirodMedical., AdamRouilly, Timesco Healthcare Ltd, Zhejiang Honsun Medical Technology Co., Ltd., IRIDEX Corporation, NIDEK CO., LTD., OSCAR BOSCAROL S.r.l., American Diagnostic Corporation, Lumenis Be Ltd., Veatch Ophthalmic Instruments, KIRCHNER & WILHELM GmbH + Co. KG, CenterVua SpA, oDocs Eye Care, and others.
North America is expected to hold the highest share in the revenue in the Ophthalmoscopes market during the forecast period. Increased prevalence of ophthalmic disease, increased prevalence of age-related macular degeneration will increase the demand for ophthalmoscopes in North America, leading to a rise in the overall ophthalmoscopes market growth in this region.